2017 Program

Monday, July 17

15:00 Arrival & Registration 
17:00 Ice Breaker – Join us on the front lawn for falconry and archery
18:30 Drinks Reception
19:00

Welcome & Participant Self-Introductions:

  • Sara Jane Demy, Founder & CEO, Demy-Colton

Fireside Chat: The Purposeful CEO—A seasoned advisor’s view on an industry in continual transformation and the CEOs that are leading the transformation

  • Interviewer: Tim Opler, Partner & Co-Founder, Torreya Partners
  • Interviewee: Dennis Purcell, Founder and Senior Advisor, Aisling Capital

Networking Dinner Reception

22:00 Conclusion of Opening Events

Tuesday, July 18

07:15 Breakfast
08:15

Overview and Rules of Engagement

  • Sara Jane Demy, Founder & CEO, Demy-Colton

Introduction of CEO Self-Assessment & Flash Surveys

08:30

DISCUSSION 1: Setting the Strategic Direction—Are the Best Opportunities Aligned to Your “Reason for Being”?

  • Ben Bonifant, Founder, Triangle Insights Group (Leader)
09:45 Morning Break
10:15

DISCUSSION 2:  Strategic Direction and The Board – When and how do you engage them in strategic discussions? 

  • Rolf Hoffmann, Senior Vice President, US Operations, Amgen (retired) (Leader)
11:15

DISCUSSION 3:  Planning for approval and commercialization early in the development process—Which steps are necessary and which are a waste of time and money?

  • Ted Haack, Vice President, LatticePoint Consulting (Leader)
12:15 Networking Lunch at Sika
13:15

DISCUSSION 4: Maximizing returns—How do you balance your shareholders’ needs, patient access, perception of your company, and perception in the industry?

  • Jim Davlin, Executive Director, Torreya Partners (Leader)
14:15

DISCUSSION 5: Money—Which of the different flavors of capital for public and private companies is best for you? (Break out into two groups)

  • Private discussion: Nooman Haque, Director of Life Sciences, Silicon Valley Bank UK (Leader)
  • Public discussion: Frederik Gorter de Vries, Vice President Life Sciences and Healthcare, Kempen & Co. (Leader)
15:15 Afternoon Break
15:30

An unguarded conversation among CEOs and friends—Barriers to building a thriving European biotech community – are times changing?

  • Frederik Gorter de Vries, Vice President Life Sciences and Healthcare, Kempen & Co. (Leader)
16:30 BIOTECH CEO SUMMIT GAMES
18:30 GALA DINNER AND AWARDS

Wednesday, July 19

07:00 Breakfast
08:00

DISCUSSION 6: Communications strategy—What is the right story for your company and how do you set the stage to deal with adversity?

  • Erik Clausen, Managing Partner, CG Life (Leader)
09:00

DISCUSSION 7: Dancing with bears —What makes for a successful alliance between “big” pharma and “small” biotech, and what makes them fail?

  • Daniel Pavin, Partner, Covington & Burling, LLP (Leader)
10:00 Morning Break
10:30

DISCUSSION 8: Team development—Does the company’s early team have the diversity of backgrounds and perspectives for later success?

  • Bianca Coulter, CEO, Coulter Partners (Leader)
11:30 

DISCUSSION 9:  Board development—How do you prod your board toward adapting to new realities and get them in alignment with your vision?

  • Jim Davlin, Executive Director, Torreya Partners (Leader)
12:30 Networking Lunch at Sika
13:30

An unguarded conversation among CEOs and friends—The characteristics of a successful biotech CEO

  • Bianca Coulter, CEO, Coulter Partners (Leader)
14:30 

DISCUSSION 10: Critical inflection points – How have you survived the make or break moments that led to success?

  • Steve Dickman, CEO, CBT Advisors (Leader)
15:30 CLOSING RECEPTION

med_9041 med_9071 med_9236